HGERS
FLNA

Householder Group Estate & Retirement Specialist’s Filana Therapeutics FLNA Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15
Closed – – 1311
2023
Q4 		$0 Hold
15
– – ﹤0.01% 1303
2023
Q3 		$250 Buy
+15
New +$297 ﹤0.01% 1224

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's FLNA Position: Q1 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Filana Therapeutics (FLNA) in Q1 2024, closing a stake of 15 shares.

Householder Group Estate & Retirement Specialist first reported a position in FLNA in Q3 2023 and held it in 2 quarters. The position peaked at $250 in Q3 2023. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Filana Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 15 Filana Therapeutics shares in Q1 2024.
  • Householder Group Estate & Retirement Specialist first reported a position in Filana Therapeutics in Q3 2023 and held it in 2 quarters.
  • Householder Group Estate & Retirement Specialist's Filana Therapeutics position peaked at $250 in Q3 2023.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q1 2024, filed 3 May 2024.